Diastematomyelia case study: A 40-year-old man with upper and lower back pain. He denied any bowel or bladder dysfunction, radiating symptoms, or motor deficits.
A 40-year-old man presented with upper and lower back pain. His symptoms worsened over the course of a month. The patient denied any bowel or bladder dysfunction, radiating symptoms, or motor deficits.
Axial T2-weighted MR images (Figures 1 and 2) reveal a longitudinally split thoracic spinal cord with cerebrospinal fluid intervening between the two hemicords (arrow). The left hemicord is slightly larger than the right hemicord. No bony spurs were identified along the course of the split cord. A sagittal T1-weighted image (Figure 3) shows bony fusion of the bodies of the T10 and T11 vertebrae.
Diastematomyelia of the thoracic spinal cord with associated vertebral body fusion.
The differential diagnosis includes diplomyelia, tethered spinal cord, thickened filum terminale, neurenteric cysts, congenital dermal sinus tract, anterior sacral meningocele, spinal lipomas, and dermoid and epidermoid tumors.
Diastematomyelia refers to a pathologic longitudinal splitting of the spinal cord and the intradorsal nerve roots into two columns. Separation into the two hemicords may be due to a bony spur, cartilaginous separation or fibrous band with a usual asymmetry in size of the hemicords.
Two types of diastematomyelia have been described. Each accounts for roughly 50% of the observed cases. Type I refers to a split cord that is surrounded by a normal undivided arachnoid-dural sleeve without a septum. Type II refers to a split cord in which each hemicord is invested by a separate dural sleeve that is divided by a fibrous, cartilaginous, or bony septum.1
Diastematomyelia usually occurs in the lower thoracic and upper lumbar regions and 85% of the time is associated with bony abnormalities including spina bifida, widened interpediculate distances, hemivertebrae, and scoliosis. There are also associated cutaneous manifestations of the dorsal midline including telangectasias, atrophic skin, hemangiomas, and subcutaneous lipomas.1,2
Patients present with a wide range of severity in their signs and symptoms, including clinically silent lesions and gait disturbance, lower extremity weakness, progressive paraparesis, and bladder and bowel dysfunction.3 Diastematomyelia is best evaluated with MRI in conjunction with CT. Diagnostic ultrasound is the modality of choice for prenatal detection, typically during the early to mid third trimester, allowing for an early surgical intervention and usually a good prognosis.
Submitted by Neil M. Gupta, M.D., radiology resident, and Michael I. Firestone, M.D., assistant professor of radiology at St. Francis Hospital in Hartford, CT.
1. Barkovich AJ, Naidich TP. Congenital anomalies of the spine; pediatric neuroimaging. New York: Raven Press; 1990:227-271.
2. Grossman R, Yousem D. The requisites: neuroradiology, 2nd ed. Philadelphia: Mosby; 2003:462-465.
3. Scotti G, Musgrave MA, Harwood-Nash DC, et al. Diastematomyelia in children: metrizamide and CT metrizamide myelography. AJR 1980;135:1225-1232.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Philips Launches Flash 5100 Point-of-Care Ultrasound System
June 17th 2025Offering a combination of intuitive touchscreen controls and enhanced image clarity, the portable Flash 5100 POC ultrasound platform reportedly facilitates confident and rapid assessment in emergency radiology and critical care settings.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.